Vectura

is an England-based pharmaceutical company that develops and commercializes inhaled medicines for the treatment of respiratory diseases...
Read more
Vectura CEO: Will Downie

CEO

Will Downie

CEO Approval Rating

90/100

Est. Annual Revenue
$100-500M
Agree?
Est. Employees
500-1.0K
Agree?
Acquisitions
2
Investments
1

Vectura Competitors

1H&T Presspart
2Pulmatrix
3Enterprise Therapeutics
4Sensirion
5OPKO
6Dezima Pharma
7Aerogen
8ReViral
9Verona Pharma
10Pulmagen Therapeutics

Trending Companies